• 11/11/2024

AstraZeneca Earnings Hit By Higher Costs

Wall Street Journal

AstraZeneca reported core earnings for the fourth quarter just short of consensus, but said it expected double-digit percentage growth in 2024.

https://www.wsj.com/articles/astrazeneca-sees-double-digit-growth-for-core-earnings-revenue-in-2024-ca5eb4ad